As shown in Fig. 1, the OX40 mRNA expression in the peripheral blood of MS patients was significantly higher in comparison to that of NMO patients (P = 0.0125) and healthy subjects (P = 0.0006). This evidence concerns the gene TNFRSF4 and myeloid sarcoma.